Company Filing History:
Years Active: 2014-2021
Title: Richard Willhelm Janssens: Innovator in Antibody Research
Introduction
Richard Willhelm Janssens is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of antibody research, holding a total of three patents. His work focuses on the development of innovative methods for generating heavy chain-only antibodies, which have important applications in medical research and therapeutics.
Latest Patents
Janssens' latest patents include groundbreaking inventions such as "Methods of making heavy chain only antibodies using transgenic animals." This invention relates to a method for generating fully functional heavy chain-only antibodies in transgenic mice in response to antigen challenge. Another significant patent is titled "Binding molecules," which pertains to the manufacture of a diverse repertoire of functional heavy chain-only antibodies that undergo affinity maturation. This invention also covers the manufacture and use of multivalent polypeptide complexes with antibody heavy chain functionality, enhancing the potential for therapeutic applications.
Career Highlights
Richard Willhelm Janssens is affiliated with the Erasmus University Medical Centre, where he conducts his research. His work has been instrumental in advancing the understanding of antibody functionality and its applications in various medical fields. His innovative approaches have positioned him as a key figure in the realm of biopharmaceutical research.
Collaborations
Janssens has collaborated with esteemed colleagues such as Dubravka Drabek and Roger Kingdon Craig. These collaborations have further enriched his research and contributed to the development of his patented technologies.
Conclusion
Richard Willhelm Janssens is a prominent inventor whose work in antibody research has led to significant advancements in the field. His innovative patents and collaborations continue to influence the landscape of medical research and therapeutic development.